我們已在上線!
進一步了解
IMV
IMV Inc. Common Shares
IMV
IMV
已下市
IMV已於2023年4月28日下市。
關於: IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.
員工: 63
新聞
正面
中性
負面
市場情緒
3個月
正面
0%
中性
0%
負面
0%
我們尚未收到任何關於IMV的最新新聞文章。
價格圖表採用Lightweight Charts™實作